Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia A Possik

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nature Cancer|May 16, 2023
Obstacles and opportunities in studying melanoma in Latin AmericaPatricia A Possik
Pigment Cell & Melanoma Research|April 11, 2012
If you can't beat me, join me: collaborating oncogenes circumventing senescence and causing cancerPatricia A Possik, Daniel S Peeper
Nature Genetics|April 16, 2025
Desmosome mutations in keratinocytes fuel melanoma developmentPatricia A Possik, Kerrie L Marie, David J Adams
Neoplasia (New York, N.Y.)|November 1, 2023
Acral melanoma: new insights into the immune and genomic landscapeLarissa Anastacio DaCosta Carvalho, Flavia C Aguiar, Keiran S M Smalley, et al.
Oncotarget|July 5, 2016
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancerSedef Iskit, Cor Lieftink, Pasi Halonen, et al.
Journal of Translational Medicine|February 7, 2020
Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironmentNatasha A N Jorge, Jéssica G V Cruz, Marco Antônio M Pretti, et al.
Biochemical and Biophysical Research Communications|September 3, 2018
Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cellsÉrika Carvalho, Vitor Hugo de Almeida, Araci M R Rondon, et al.
Journal of Proteome Research|August 29, 2015
PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular NetworksLinsey M Raaijmakers, Piero Giansanti, Patricia A Possik, et al.
The Journal of Pathology. Clinical Research|July 2, 2021
More than just acral melanoma: the controversies of defining the diseaseSara S Bernardes, Ingrid Ferreira, David E Elder, et al.
Molecular Systems Biology|December 25, 2014
ROCK1 is a potential combinatorial drug target for BRAF mutant melanomaMarjon A Smit, Gianluca Maddalo, Kylie Greig, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nature Cancer|May 16, 2023
Obstacles and opportunities in studying melanoma in Latin AmericaPatricia A Possik
Pigment Cell & Melanoma Research|April 11, 2012
If you can't beat me, join me: collaborating oncogenes circumventing senescence and causing cancerPatricia A Possik, Daniel S Peeper
Nature Genetics|April 16, 2025
Desmosome mutations in keratinocytes fuel melanoma developmentPatricia A Possik, Kerrie L Marie, David J Adams
Neoplasia (New York, N.Y.)|November 1, 2023
Acral melanoma: new insights into the immune and genomic landscapeLarissa Anastacio DaCosta Carvalho, Flavia C Aguiar, Keiran S M Smalley, et al.
Oncotarget|July 5, 2016
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancerSedef Iskit, Cor Lieftink, Pasi Halonen, et al.
Journal of Translational Medicine|February 7, 2020
Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironmentNatasha A N Jorge, Jéssica G V Cruz, Marco Antônio M Pretti, et al.
Biochemical and Biophysical Research Communications|September 3, 2018
Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cellsÉrika Carvalho, Vitor Hugo de Almeida, Araci M R Rondon, et al.
Journal of Proteome Research|August 29, 2015
PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular NetworksLinsey M Raaijmakers, Piero Giansanti, Patricia A Possik, et al.
The Journal of Pathology. Clinical Research|July 2, 2021
More than just acral melanoma: the controversies of defining the diseaseSara S Bernardes, Ingrid Ferreira, David E Elder, et al.
Molecular Systems Biology|December 25, 2014
ROCK1 is a potential combinatorial drug target for BRAF mutant melanomaMarjon A Smit, Gianluca Maddalo, Kylie Greig, et al.
Pageof 3